Ürünlerimiz

LS-1100 uses the advanced method of Time-resolved Fluorescence Immunoassay (TRFIA), for the in-vitro quantitative detection of bio-markers for diabetes, infectious diseases, cardiovascular diseases, sex hormones, gastric diseases, thyroid function, tumors, COVID-19 and other diseases.

Application: laboratory, emergency , ICU, clinical laboratory, clinic, ambulance, field rescue and other clinical departments, etc.

LS-2100 uses the advanced method of Time-resolved Fluorescence Immunoassay (TRFIA), for the in-vitro quantitative detection of bio-markers for diabetes, infectious diseases, cardiovascular diseases, sex hormones, gastric diseases, thyroid function, tumors, COVID-19 and other diseases.

Application: laboratory, emergency , ICU, clinical laboratory, clinic, ambulance, field rescue and other clinical departments, etc.

LS-1100 uses the advanced method of Time-resolved Fluorescence Immunoassay (TRFIA), for the in-vitro quantitative detection of bio-markers for diabetes, infectious diseases, cardiovascular diseases, sex hormones, gastric diseases, thyroid function, tumors, COVID-19 and other diseases.

Application: laboratory, emergency , ICU, clinical laboratory, clinic, ambulance, field rescue and other clinical departments, etc.

The handheld coagulation analyzer is used in conjunction with the electrochemical kit produced by Lansion Biotechnology Co., Ltd., and can be used for quantitative measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT), fibrinogen (FIB), thrombin time (TT), activated clotting time (ACT) in human whole blood or peripheral blood. The test results are used for assisting clinical diagnosis.